LPS-induced G-CSF expression in macrophages is mediated by ERK2, but not ERK1

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chang, Shwu Fen ^a   Lin, Shih Shan ^b   Yang, Hui Ching ^b   Chou, Yuan Yi ^b   Gao, Jhen I ^b   Lu, Shao Chun ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; DEOXYRIBONUCLEASE I; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; DEOXYRIBONUCLEASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; PROTEIN BINDING; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PLASMID; POINT MUTATION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; BUTADIENES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; DEOXYRIBONUCLEASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GRANULOCYTE COLONY-STIMULATING FACTOR; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NF-KAPPA B; NITRILES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASE INHIBITORS;

EID: 84938499450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129685     Document Type: Article

References (43)

1. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-1746. PMID: 7521686
2. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791-2808. PMID: 1720034
3. Hareng L, Hartung T. Induction and regulation of endogenous granulocyte colony-stimulating factor formation. Biol Chem. 2002; 383: 1501-1517. PMID: 12452428
4. Nishizawa M, Tsuchiya M, Watanabe-Fukunaga R, Nagata S. Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells. J Biol Chem. 1990; 265: 5897-5902. PMID: 1690717
5. Nishizawa M, Nagata S. Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol Cell Biol. 1990; 10: 2002-2011. PMID: 1691438
6. Chou YY, Gao JI, Chang SF, Chang PY, Lu SC. Rapamycin inhibits lipopolysaccharide induction of granulocyte-colony stimulating factor and inducible nitric oxide synthase expression in macrophages by reducing the levels of octamer-binding factor-2. FEBS J. 2011; 278: 85-96. doi: 10.1111/j.1742-4658.2010.07929.x PMID: 21114628
7. Akashi M, Shaw G, Hachiya M, Elstner E, Suzuki G, Koeffler P, et al. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs. Blood 1994; 83: 3182-3187. PMID: 8193353
8. Brown CY, Lagnado CA, Vadas MA, Goodall GJ. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem. 1996; 271: 20108-20112. PMID: 8702732
9. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000; 68: 144-150. PMID: 10914502
10. Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol. 2006; 2: 500-510. PMID: 16951705
11. Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, et al. High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2000; 18: 713-718. PMID: 11138333
12. Wright HL, Bucknall RC, Moots RJ, Edwards SW. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology 2012; 51: 451-459. doi: 10.1093/rheumatology/ker338 PMID: 22179732
13. Kojima K, Nakashima F, Boku A, Muroishi Y, Nakanishi I, Oda Y. Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis. Histol. Histopathol. 2002; 17: 1005-1016. PMID: 12371127
14. Araki K, Kishihara F, Takahashi K, Matsumata T, Shimura T, Suehiro T, et al. Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int. 2007; 27: 716-721. PMID: 17498259
15. Endo K, Kohnoe S, Okamura T, Haraguchi M, Adachi E, Toh Y, et al. Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 2005; 8: 173-177. PMID: 16086120
16. Joshita S, Nakazawa K, Sugiyama Y, Kamijo A, Matsubayashi K,Miyabayashi H, et al. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Intern Med. 2009; 48: 687-691. PMID: 19420814
17. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001; 13: 85-94. PMID: 11257452
18. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000; 103: 1071-1083. PMID: 11163183
19. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001; 98: 1429-1439. PMID: 11520792
20. Yang SH, Vickers E, Brehm A, Kouzarides T, Sharrocks AD. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol Cell Biol. 2001; 21: 2802-2814. PMID: 11283259
21. Makuta Y, Sonoda Y, Yamamoto D, Funakoshi-Tago M, Aizu-Yokota E, Takebe Y, et al. Interleukin-10-induced CCR5 expression in macrophage like HL-60 cells: involvement of Erk1/2 and STAT-3. Biol Pharm Bull. 2003; 26: 1076-1081. PMID: 12913253
22. Hu J, Roy SK, Shapiro PS, Rodig SR, Reddy SP, Platanias LC, et al. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem. 2001; 276: 287-297. PMID: 10995751
23. Lee CH, Lin SH, Chang SF, Chang PY, Yang ZP, Lu SC. Extracellular signal-regulated kinase 2 mediates the expression of granulocyte colony-stimulating factor in invasive cancer cells. Oncol Rep. 2013; 30: 419-424. doi: 10.3892/or.2013.2463 PMID: 23674093
24. Chou SF, Chen HL, Lu SC. Up-regulation of human deoxyribonuclease II gene expression during myelomonocytic differentiation of HL-60 and THP-1 cells. Biochem Biophys Res Commun. 2002; 296: 48-53. PMID: 12147225
25. Lu SC, Chang SF, Chen HL, Chou YY, Lan YH, Chuang CY, et al. A novel role for Oct-2 in the lipopolysaccharide-mediated induction of resistin gene expression in RAW264.7 cells. Biochem J. 2007; 402: 387-395. PMID: 17107342
26. Hanlon M, Sturgill TW, Sealy L. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/ enhancer-binding protein-beta interaction with serum response factor. J Biol Chem. 2001; 276: 38449-38456. PMID: 11500490
27. Roy SK, Hu J, Meng Q, Xia Y, Shapiro PS, Reddy SP, et al. MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 2002; 99: 7945-7950. PMID: 12048245
28. Roy SK, Shuman JD, Platanias LC, Shapiro PS, Reddy SP, Johnson PF, et al. A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-β-dependent gene expression in response to interferon-ã. J Biol Chem. 2005; 280: 24462-24471. PMID: 15878863
29. Drobic B, Pérez-Cadahía B, Yu J, Kung SK, Davie JR. Promoter chromatin remodeling of immediateearly genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res. 2010; 38: 3196-3208. doi: 10.1093/nar/gkq030 PMID: 20129940
30. Yao Y, Li W, Wu J, Germann UA, Su MS, Kuida K, et al. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 2003; 100: 12759-12764. PMID: 14566055
31. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol. 2006; 5: 14. PMID: 16805921
32. Ajenjo N, Cañón E, Sánchez-Pérez I, Matallanas D, León J, Perona R, et al. Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells. J Biol Chem. 2004; 279: 32813-32823. PMID: 15173174
33. Cockerill PN. Structure and function of active chromatin and DNase I hypersensitive sites. FEBS J. 2011; 278: 2182-2210. doi: 10.1111/j.1742-4658.2011.08128.x PMID: 21501387
34. Carlson SM, Chouinard CR, Labadorf A, Lam CJ, Schmelzle K, Fraenkel E, et al. Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal. 2011; 4: rs11.
35. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, Watowich SS, et al. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol. 2007; 179: 7215-7219. PMID: 18025162
36. Chen BC, Lin WW. PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. Br J Pharmacol. 2001; 134: 1055-1065. PMID: 11682454
37. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway. J Biol Chem. 1998; 273:6607-6610. PMID: 9506955
38. Rego D, Kumar A, Nilchi L, Wright K, Huang S, Kozlowski M. IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/ enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages. J Immunol. 2011; 186: 5443-5456. doi: 10.4049/jimmunol.1003551 PMID: 21422245
39. Jin Y, Liu Y, Nelin LD. Extracellular signal-regulated kinase mediates expression of arginase II but not inducible nitric-oxide synthase in lipopolysaccharide-stimulated macrophages. J Biol Chem. 2015; 290:2099-2111. doi: 10.1074/jbc.M114.599985 PMID: 25451938
40. Cho YC, Ju A, Kim BR, Cho S. Anti-inflammatory effects of Crataeva nurvala Buch. Ham. are mediated via inactivation of ERK but not NF-κB. J Ethnopharmacol. 2015; 162:140-147. doi: 10.1016/j.jep.2014.12.056 PMID: 25571844
41. Schwabe RF, Sakurai H. IKKbeta phosphorylates p65 at S468 in transactivaton domain 2. FASEB J. 2005; 19:1758-1760. PMID: 16046471
42. Kleinert H, Schwarz PM, Förstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem. 2003; 384:1343-1364. PMID: 14669979
43. Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, et al. A key role for G-CSFi-nduced neutrophil production and trafficking during inflammatory arthritis. Blood 2008; 112: 5193-5201. doi: 10.1182/blood-2008-02-139535 PMID: 18824600